-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

332. Anticoagulation and Antithrombotic Therapies: Poster II Clinically Relevant Abstract

Program: Oral and Poster Abstracts
Type: Poster
Sunday, December 12, 2021: 6:00 PM-8:00 PM
Hall B5, Level 1, Building B (Georgia World Congress Center)

Craig I. Coleman, PharmD1*, Kimberly Snow Caroti, PharmD2*, Khaled Abdelgawwad, MSc, MBA3*, George Psaroudakis, PhD4*, Samuel Fatoba4*, Marcela Rivera, PhD4*, Gunnar Brobert, PhD4* and Christopher Brescia, BS5*

1School of Pharmacy, University of Connecticut, WEST SUFFIELD, CT
2Evidence-Based Practice Center, Hartford Hospital, Hartford, CT
3Thrombosis and Opthalmology, Bayer AG, Berlin, Germany
4Bayer AG, Berlin, Germany
5Freshtech IT, LLC, East Hartford, CT

Willem Brandt1*, Cameron Brown1,2*, Amin Zahrai, MSc3,4*, Ranjeeta Mallick, PhD, MSc, BSc5*, Philip S. Wells, MD, MSc, FRCP5,6,7 and Marc Carrier8

1Department of Medicine, University of Ottawa/The Ottawa Hospital, Ottawa, ON, Canada
2Faculty of Arts and Science, Queen's University, Kingston, ON, Canada
3University of Ottawa, Ottawa, ON, Canada
4Ottawa Hospital Research Institute, Ottawa, ON, ON, Canada
5Ottawa Hospital Research Institute, Ottawa, ON, Canada
6Department of Medicine, University of Ottawa, Ottawa, ON, Canada
7The Ottawa Hospital, Ottawa, ON, Canada
8Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, ON, ON, Canada

Paola Alejandra Barzallo Burbano, MD1*, Mar Meijón, MD2*, Nuria Revilla Calvo, MD2*, María Jesús Blanco Bañares, MD3*, Begoña Fernández, MD4*, Ramón Rodríguez-González, MD5*, María Elena Sola Aparicio, MD6*, Belén Rosado Sierra, MD6*, Susana Asenjo Correa, MD7*, Isabel Gutiérrez, MD8*, María Pilar Llamas Sillero, MD, PhD9*, José L. Díez-Martín, MD, PhD1, Gloria Pérez-Rus, MD, PhD1* and Cristina Pascual Izquierdo, PhD, MD1*

1Hematology Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain
2Hematology and Hemotherapy Department, Hospital Universitario Ramón y Cajal, Madrid, Spain
3Hospital Universitario La Paz, Madrid, Spain
4Hematology Department, Hospital Universitario de Móstoles, Madrid, Spain
5Hospital Universitario Severo Ochoa, Madrid, Spain
6Hospital Universitario Rey Juan Carlos, Madrid, Spain
7Hospital Clínico San Carlos, Madrid, Spain
8Hematology Department, Hospital Universitario Príncipe de Asturias, Madrid, Spain
9Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain

Maha AT Elsebaie, MBBCh1, Zoe Alexandra Wickham, MPH2*, Stephanie Debragga3*, Juan Li4* and Manila Gaddh, MD5

1Department of Medicine, John H. Stroger Hospital of Cook County, Chicago, IL
2Emory Winship Cancer Institute, Emory University, ATLANTA, GA
3Winship Cancer Institute of Emory University, Atlanta
4Emory University, ATLANTA, GA
5Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA

Huong Chi Mai Tran1*, Rania Amrane1*, Elisabeth Mbemba2*, Michele Sabbah3*, Ismail Elalamy, MD, PhD4, Jawed Fareed, PhD5, Patrick Van Dreden, PhD6 and Grigorios T. Gerotziafas7,8*

1Diagnostica Stago, Gennevilliers, France
2Inserm U938, Paris, France
3Sorbonne Université-Inserm, CNRS, Umr_s938, 75012, France
4Hôpital Tenon, Hopitaux Universitaires de l'Est Parisien, Assistance Publique Hôpitaux de Paris, Faculté de Médecine, Sorbonne Université,, Hematology and Thrombosis Center, Paris, France
5Pathology, Loyola University Medical Center, Bldg. 115 Room 432, IL
6Clinical Research, Stago, Gennevilliers, France
7INSERM U938, Faculté de Médecine Pierre et Marie Curie, Université Paris VI,, Paris, France
8Service d'hématologie clinique et de thérapie cellulaire, Saint Antoine Hospital, Paris, France

Kanak Parmar1*, Wasawat Vutthikraivit1*, Amritpal Singh2*, Christina Morataya1*, Gaspar Del Rio Pertuz1*, Annia Cavazos1*, Lukman Tijani, MD3*, Kenneth Nugent4* and Erwin Argueta5*

1Texas Tech University Health Sciences Center, Lubbock, TX
2Adesh University, Bathinda, India
3Hematology Oncology Department, Texas Tech University Health Science Center, Lubbock, TX
4Department of Pulmonary and Critical Care, Texas Tech University Health Sciences Center, Lubbock, TX
5Department of Cardiology, Texas Tech University Health Sciences Center, Lubbock, TX

Phyu Thin Naing, MBBS1, Hadya Elshakh, MD2*, Lauren Elreda, MD3*, Joon Ha Woo, DO3*, Michael Karass, MD3*, John Prudenti, DO3* and Alan Wu4*

1Internal Medicine, New York-Presbyterian Queens, Elmhurst, NY
2New York- Presbyterian Queens, Flushing, NY
3New York-Presbyterian Queens, Flushing, NY
4Department of Population Health Sciences, Weill Cornell Medicine, New York, NY

Allen Li, BHSc1*, Willem Brandt2*, Cameron Brown2*, Tzu-Fei Wang, MD3, Rick Ikesaka, MD4*, Aurelien Delluc, MD, PhD5*, Philip S. Wells, MD, MSc, FRCP2,6,7 and Marc Carrier5

1University of Ottawa/The Ottawa Hospital, Ottawa, ON, Canada
2Ottawa Hospital Research Institute, Ottawa, ON, Canada
3Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada
4Department of Medicine, McMaster University, Hamilton, ON, Canada
5Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, ON, ON, Canada
6Department of Medicine, University of Ottawa, Ottawa, ON, Canada
7The Ottawa Hospital, Ottawa Blood Disease Centre, Ottawa, ON, Canada

*signifies non-member of ASH